Research for January 29, 2020
advertisement
- Yield of a Public Health Screening of Children for Islet Autoantibodies in Bavaria, Germany
- Diabetic Neuropathy Is a Substantial Burden in People With Type 1 Diabetes and Is Strongly Associated With Socioeconomic Disadvantage: A Population-Representative Study From Scotland (HTML)
- Modulating the immune system to delay the clinical onset of type 1 diabetes (HTML)
- Parent Preferences for Delaying Insulin Dependence in Children at Risk of Stage III Type 1 Diabetes (HTML)
- World-first diabetes research to follow babies from pregnancy to early childhood
- Type 1 diabetes in children born after assisted reproductive technology: a register-based national cohort study (HTML)
- Clinical trial data validate the C-peptide estimate model in type 1 diabetes
- Childhood type 1 diabetes: an environment-wide association study across England
- Role of Glucagon in Automated Insulin Delivery (HTML)
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial (HTML)
- Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols (HTML)
- Gluten-free diet in children with recent-onset type 1 diabetes: a 12-month intervention trial (HTML)
- Determinants of Vitamin D Supplementation among Individuals with Type 1 Diabetes
- Decreased markers of bone turnover in children and adolescents with type 1 diabetes (HTML)
- Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II (HTML)
- Epigenetic biomarkers indicate islet cell death in xenotransplantation (HTML)
- Pancreatic α-cells – The unsung heroes in islet function (HTML)
- New insight in endocrine-related adverse events associated to immune checkpoint blockade (HTML)
- A Deep Neural Network Application for Improved Prediction of HbA1c in Type 1 Diabetes (HTML)
- Costs and outcomes of ‘intermediate’ versus ‘minimal’ care for youth-onset type 1 diabetes in six countries (HTML)
